OU Medicine, OU Health Sciences Center and Oklahoma Blood Institute are collaborating to determine the prevalence of Oklahoma healthcare workers who have previously been infected with the COVID-19 virus.
SCC participated in clinical trial proving effectiveness of an oral medication in key treatment advance.
Michael Cookson, M.D., chair of urology at the University of Oklahoma College of Medicine and Tyler Gunter, M.D., OU Medicine radiation oncologist, will discuss treatment options available at Stephenson Cancer Center.
Emergency medical care should never be delayed, and OU Medicine has implemented extensive protocols to ensure patients are kept safe in the Emergency Department as COVID-19 infections continue in Oklahoma.